These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9889947)

  • 1. The effect of Losartan on red blood cell deformability and tissue oxygenation in patients with arterial hypertension.
    Cicco G; van der Kleij AJ; Manicone A; Vicenti P; Dolce E; Pirelli A
    Adv Exp Med Biol; 1998; 454():663-6. PubMed ID: 9889947
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of angiotensin II receptors antagonist losartan on metabolism and morphofunctional condition myocardium in hypertensive patients].
    Didenko VA; Simonov DV
    Klin Med (Mosk); 1998; 76(9):33-7. PubMed ID: 9821371
    [No Abstract]   [Full Text] [Related]  

  • 3. [REGRESSION OF LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH ESSENTIAL HYPERTENSION AND LONG-TERM THERAPY WITH LOSARTAN].
    Dotsenko SY; Tokarenko AA; Tokarenko II
    Lik Sprava; 2015; (7-8):17-21. PubMed ID: 27491145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro effect of nicotine on red blood cell deformability in untreated and treated essential hypertension.
    Salbaş K; Gürlek A; Akyol T
    Scand J Clin Lab Invest; 1994 Dec; 54(8):659-63. PubMed ID: 7709169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of aspirin on rheological properties of erythrocytes in essential hypertension].
    Korbut RA; Adamek-Guzik T
    Przegl Lek; 2002; 59(2):71-5. PubMed ID: 12152252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of alpha-blocker on hemorheology in patients with essential hypertension.
    Gomi T; Ikeda T; Ikegami F
    Am J Hypertens; 1997 Aug; 10(8):886-92. PubMed ID: 9270083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting hemodynamic mechanisms of losartan- vs. atenolol-based antihypertensive treatment: a LIFE study.
    Greve AM; Olsen MH; Bella JN; Lønnebakken MT; Gerdts E; Okin PM; Palmieri V; Boman K; Nieminen MS; Omvik P; Dahlöf B; Devereux RB; Wachtell K
    Am J Hypertens; 2012 Sep; 25(9):1017-23. PubMed ID: 22695506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Estimation of blood pressure, selected biochemical parameters and indices of left ventricular heart function in patients with mild or moderate essential hypertension treated with potassium losartan].
    Hrycek A; Badowski R; Scieszka J; Haczkiewicz P; Hefczyc J; Cieślik P
    Pol Arch Med Wewn; 2001 Oct; 106(4):891-9. PubMed ID: 11993408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of the antihypertensive activities of losartan and HM70186 during liver dysfunction.
    Lee S
    Arch Pharm Res; 2009 Jul; 32(7):965-6. PubMed ID: 19641875
    [No Abstract]   [Full Text] [Related]  

  • 10. [The normalized smoothness index and parametric population RDH index of losartan in patients with newly diagnosed hypertension and metabolic syndrome].
    Rihácek I; Frána P; Schwarz D; Plachý M; Soucek M
    Vnitr Lek; 2010 Sep; 56(9):901-9. PubMed ID: 21137176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Israeli experiences of treatment of hypertension with losartan (Ocsaar)--summary of the treatment of 421 patients in community health centers].
    Zimlichman R
    Harefuah; 1999 Dec; 137(12):597-603, 680. PubMed ID: 10959382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of barnidipine 10 or 20 mg plus losartan 50-mg combination versus losartan 100-mg monotherapy in patients with essential hypertension not controlled by losartan 50-mg monotherapy: A 12-week, multicenter, randomized, open-label, parallel-group study.
    Parati G; Giglio A; Lonati L; Destro M; Ricci AR; Cagnoni F; Pini C; Venco A; Maresca AM; Monza M; Grandi AM; Omboni S
    Clin Ther; 2010 Jul; 32(7):1270-84. PubMed ID: 20678675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral vasomotor reactivity before and after blood pressure reduction in hypertensive patients.
    Claassen JA; Levine BD; Zhang R
    Am J Hypertens; 2009 Apr; 22(4):384-91. PubMed ID: 19229191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study.
    Naritomi H; Fujita T; Ito S; Ogihara T; Shimada K; Shimamoto K; Tanaka H; Yoshiike N
    Hypertens Res; 2008 Feb; 31(2):295-304. PubMed ID: 18360050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term central hemodynamic effects at rest and during exercise of losartan in essential hypertension.
    Omvik P; Gerdts E; Myking OL; Lund-Johansen P
    Am Heart J; 2000 Oct; 140(4):624-30. PubMed ID: 11011337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Angiotensin-II receptor inhibitors in hemodialysed uremia patients with arterial hypertension: candesartan cilexitil versus losartan].
    Cice G; Ferrara L; Tagliamonte E; Russo PE; Di Benedetto A; Iacono A
    Cardiologia; 1999 Dec; 44(12):1071-6. PubMed ID: 10687258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of losartan and hydrochlorothiazide on exercise tolerance in exertional hypertension and left ventricular diastolic dysfunction.
    Little WC; Zile MR; Klein A; Appleton CP; Kitzman DW; Wesley-Farrington DJ
    Am J Cardiol; 2006 Aug; 98(3):383-5. PubMed ID: 16860028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive treatment and sympathetic excitation.
    Malliani A; Montano N
    Hypertension; 2005 Sep; 46(3):e8; author reply e8. PubMed ID: 16123377
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of pulse pressure with new-onset atrial fibrillation in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint (LIFE) reduction in hypertension study.
    Larstorp AC; Ariansen I; Gjesdal K; Olsen MH; Ibsen H; Devereux RB; Okin PM; Dahlöf B; Kjeldsen SE; Wachtell K
    Hypertension; 2012 Aug; 60(2):347-53. PubMed ID: 22753219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.